Myelofibrosis | Blood Cancers Today
Myelofibrosis (MF) is a rare blood cancer that leads to scarring in the bone marrow, which alters the normal production of blood cells. Get the latest research and news.
Myelofibrosis (MF) is a rare blood cancer that leads to scarring in the bone marrow, which alters the normal production of blood cells. Get the latest research and news.
Prefibrotic PMF is an MPN with distinct characteristics comprising histopathological, clinical, and biological parameters.
A 60-year-old woman presented with anemia (hemoglobin, 8.7 g/dL), leukopenia (2.9 × 10 9 /L), and mild thrombocytopenia (135 × 10 9 /L). Bone marrow…
The panel discussed ALL treatment, associated toxicities, and the possibility of a chemotherapy-free approach.
May 31 – Jun 4 | ASCO CME Symposium Series | Chicago, IL All events are complimentary.
Asisten 170 profesionales procedentes de diversos puntos de la región y del país
Por 3 a 2, ministros avaliaram que pena ‘prescreveu’ – ou seja, prazo para punir foi ultrapassado. Ex-ministro foi condenado por corrupção e lavagem de…
Research To Practice requires users to log in to view educational content. All content is available without
The US FDA has granted accelerated approval for liso-cel in adult patients with relapsed or refractory follicular lymphoma.
Coming soon! – TMAP The IMS remains focused on providing support and educational tools to help oncologists and hematologists world-wide with treatment decisions for myeloma…
Review exclusive coverage of the MPN-focused discussions and insights from The HemOnc Pulse Live, May 3-4, 2024, in Chicago.